Gross Profit On Sales Endring Dato
Adcock Ingram Holdings ZAR 1.55B 93.45M 2023-06
Deva Holding AS TRY 1.32B 235.77M 2023-09
Ecofibre AUD 14.77M 5.73M 2023-06
Eli Lilly USD 7.57B 73.1M 2023-12
Kangmei Pharma CNY 170.43M 55.42M 2023-09
Knight Therapeutics CAD 40.18M 2.69M 2023-09
Laboratorios Farma EUR 217.46M 75.84M 2023-06
Malin Corporation EUR 3.8M 2.6M 2020-12
Medical Developments International AUD 12.32M 2.43M 2023-06
Nektar Therapeutics USD 11.71M 1.79M 2023-09
Organigram Holdings CAD -13092000 8.77M 2023-03
Pacira USD 133.55M 9.38M 2023-12
Perrigo USD 411.2M 16.8M 2023-09
Pharma Mar EUR 34.31M 10.01M 2023-09
Probiotec AUD 32.47M 597.51K 2023-06
Qiagen NV USD 297.96M 14.19M 2023-09
Sartorius EUR 359.9M 47M 2023-09
Sino Biopharmaceutical CNY 12.02B 1.27B 2023-06
Supernus Pharmaceuticals USD 144.69M 10.41M 2023-12
Zz Pientze Pharmaceu 1.28B 201.8M 2023-09



Xeris Pharmaceuticals Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.